【药物名称】DHET-PGE2
化学结构式(Chemical Structure):
参考文献No.43273
标题:11-(2-Hydroxyethylthio)prostenoic acid E{HD 2 {B series derivatives
作者:Weiss, M.J.; Siuta, G.J. (American Cyanamid Co.)
来源:US 4085272
合成路线图解说明:

The hydrogenation of ethyl 3-(2-furyl)acrylate (I) with H2 over Raney-Ni in ethanol gives ethyl 3-(2-furyl)propionate (II), which oxidative methoxylation with Br2 in methanol affords ethyl 3-(2,5-dimethoxy-2,5-dihydro-2-furyl)propionate (III). The partial reduction of (III) with diisobutylaluminum hydride in toluene yields the substituted propionaldehyde (IV), which by a Wittig condensation with 4-carboxybutyl triphenylphosphonium bromide by means of NaH in DMSO gives 8-(2,5-dimethoxy-2,5-dihydro-2-furyl)-5-octenoic acid (VI). The hydrolytic ring opening of (VI), followed by an aldol cyclization in refluxing dioxane - water by means of sodium acetate - NaH2PO4 - hydroquinone affords 7-(2-oxo-5-hydroxycyclopent-3-en-1-yl)-5-heptenoic acid (VII), which is isomerized by treatment with H2SO4 yielding 7-(5-oxo-3-hydroxycyclopenten-1-yl)-5-heptenoic acid (VIII). Methylation and esterification of (VIII) with H2SO4/refluxing methanol gives the methoxy methyl ester (IX), which by reaction with 2-mercaptoethanol (A) and sodium methoxide in methanol is converted into methyl 7-[5-oxo-3-(2-hydroxyethylthio)cyclopenten-1-yl]-5-heptenoate (X). The methylation of acid (VI) with NaH and methyl iodide gives the corresponding methyl ester (XIV), which is submitted to a hydrolytic ring opening and aldol cyclization as before to afford methyl 7-(2-oxo-5-hydroxycyclopent-3-en-1-yl)-5-heptenoate (XV). The silylation of (XV) with trimethylchlorosilane and hexamethyldisilazane as usual yields the corresponding trimethylsilyloxy derivative (XVI), which is treated with 2-mercaptoethanol (A) and sodium methoxide to give the isomerized compound (X).

合成路线图解说明:

The protection of the free hydroxy group of (X) with trimethylchlorosilane and hexamethyldisilazane in pyridine gives the trimethylsilyl derivative (XI), which is condensed with [3-(triphenylmethoxy)-1-octenyl](pentenyl)lithiocuprate (XII) in HMPT-ether to afford 11-deoxy-11alpha-(2-trimethyl-silyloxyethylthio)-15-triphenylmethoxy-PGE2 methyl ester (XIII). Finally, this compound is deprotected by treatment with acetic acid in THF. The lithium cuprate (XII) is prepared as follows: Hydrogen iodide addition to 3-triphenylmethoxy-1-octyne (XVII) gives 1-iodo-3-triphenylmethoxy-1-octene (XVIII), which is condensed with copper 1-pentyne (B) and butyllithium in ether.

参考文献No.576910
标题:DHET-PGE2
作者:Hillier, K.; Serradell, M.N.; Blancafort, P.; Casta馿r, J.
来源:Drugs Fut 1982,7(4),241
合成路线图解说明:

The hydrogenation of ethyl 3-(2-furyl)acrylate (I) with H2 over Raney-Ni in ethanol gives ethyl 3-(2-furyl)propionate (II), which oxidative methoxylation with Br2 in methanol affords ethyl 3-(2,5-dimethoxy-2,5-dihydro-2-furyl)propionate (III). The partial reduction of (III) with diisobutylaluminum hydride in toluene yields the substituted propionaldehyde (IV), which by a Wittig condensation with 4-carboxybutyl triphenylphosphonium bromide by means of NaH in DMSO gives 8-(2,5-dimethoxy-2,5-dihydro-2-furyl)-5-octenoic acid (VI). The hydrolytic ring opening of (VI), followed by an aldol cyclization in refluxing dioxane - water by means of sodium acetate - NaH2PO4 - hydroquinone affords 7-(2-oxo-5-hydroxycyclopent-3-en-1-yl)-5-heptenoic acid (VII), which is isomerized by treatment with H2SO4 yielding 7-(5-oxo-3-hydroxycyclopenten-1-yl)-5-heptenoic acid (VIII). Methylation and esterification of (VIII) with H2SO4/refluxing methanol gives the methoxy methyl ester (IX), which by reaction with 2-mercaptoethanol (A) and sodium methoxide in methanol is converted into methyl 7-[5-oxo-3-(2-hydroxyethylthio)cyclopenten-1-yl]-5-heptenoate (X). The methylation of acid (VI) with NaH and methyl iodide gives the corresponding methyl ester (XIV), which is submitted to a hydrolytic ring opening and aldol cyclization as before to afford methyl 7-(2-oxo-5-hydroxycyclopent-3-en-1-yl)-5-heptenoate (XV). The silylation of (XV) with trimethylchlorosilane and hexamethyldisilazane as usual yields the corresponding trimethylsilyloxy derivative (XVI), which is treated with 2-mercaptoethanol (A) and sodium methoxide to give the isomerized compound (X).

合成路线图解说明:

The protection of the free hydroxy group of (X) with trimethylchlorosilane and hexamethyldisilazane in pyridine gives the trimethylsilyl derivative (XI), which is condensed with [3-(triphenylmethoxy)-1-octenyl](pentenyl)lithiocuprate (XII) in HMPT-ether to afford 11-deoxy-11alpha-(2-trimethyl-silyloxyethylthio)-15-triphenylmethoxy-PGE2 methyl ester (XIII). Finally, this compound is deprotected by treatment with acetic acid in THF. The lithium cuprate (XII) is prepared as follows: Hydrogen iodide addition to 3-triphenylmethoxy-1-octyne (XVII) gives 1-iodo-3-triphenylmethoxy-1-octene (XVIII), which is condensed with copper 1-pentyne (B) and butyllithium in ether.

参考文献No.576923
标题:Prostaglandins and congeners. 22. Synthesis of 11-substituted derivatives of 11-deoxyprostaglandins E1 and E2. Potential bronchodilators
作者:Floyd, M.; Schaub, R.E.; Siuta, G.J.; Skotnicki, J.S.; Grudzinskas, C.V.; Weiss, M.J.; Dessy, F.; VanHumbeeck, L.
来源:J Med Chem 1980,23(8),903-913
合成路线图解说明:

The hydrogenation of ethyl 3-(2-furyl)acrylate (I) with H2 over Raney-Ni in ethanol gives ethyl 3-(2-furyl)propionate (II), which oxidative methoxylation with Br2 in methanol affords ethyl 3-(2,5-dimethoxy-2,5-dihydro-2-furyl)propionate (III). The partial reduction of (III) with diisobutylaluminum hydride in toluene yields the substituted propionaldehyde (IV), which by a Wittig condensation with 4-carboxybutyl triphenylphosphonium bromide by means of NaH in DMSO gives 8-(2,5-dimethoxy-2,5-dihydro-2-furyl)-5-octenoic acid (VI). The hydrolytic ring opening of (VI), followed by an aldol cyclization in refluxing dioxane - water by means of sodium acetate - NaH2PO4 - hydroquinone affords 7-(2-oxo-5-hydroxycyclopent-3-en-1-yl)-5-heptenoic acid (VII), which is isomerized by treatment with H2SO4 yielding 7-(5-oxo-3-hydroxycyclopenten-1-yl)-5-heptenoic acid (VIII). Methylation and esterification of (VIII) with H2SO4/refluxing methanol gives the methoxy methyl ester (IX), which by reaction with 2-mercaptoethanol (A) and sodium methoxide in methanol is converted into methyl 7-[5-oxo-3-(2-hydroxyethylthio)cyclopenten-1-yl]-5-heptenoate (X). The methylation of acid (VI) with NaH and methyl iodide gives the corresponding methyl ester (XIV), which is submitted to a hydrolytic ring opening and aldol cyclization as before to afford methyl 7-(2-oxo-5-hydroxycyclopent-3-en-1-yl)-5-heptenoate (XV). The silylation of (XV) with trimethylchlorosilane and hexamethyldisilazane as usual yields the corresponding trimethylsilyloxy derivative (XVI), which is treated with 2-mercaptoethanol (A) and sodium methoxide to give the isomerized compound (X).

合成路线图解说明:

The protection of the free hydroxy group of (X) with trimethylchlorosilane and hexamethyldisilazane in pyridine gives the trimethylsilyl derivative (XI), which is condensed with [3-(triphenylmethoxy)-1-octenyl](pentenyl)lithiocuprate (XII) in HMPT-ether to afford 11-deoxy-11alpha-(2-trimethyl-silyloxyethylthio)-15-triphenylmethoxy-PGE2 methyl ester (XIII). Finally, this compound is deprotected by treatment with acetic acid in THF. The lithium cuprate (XII) is prepared as follows: Hydrogen iodide addition to 3-triphenylmethoxy-1-octyne (XVII) gives 1-iodo-3-triphenylmethoxy-1-octene (XVIII), which is condensed with copper 1-pentyne (B) and butyllithium in ether.

参考文献No.800400
标题:Prostaglandins and congeners. 18. Synthesis of cyclopentenolone precursors to prostaglandins from 2,5-dihydro-2,5-dimethoxyfurans
作者:Floyd, M.B.
来源:J Org Chem 1978,43(9),1641-43
合成路线图解说明:

The hydrogenation of ethyl 3-(2-furyl)acrylate (I) with H2 over Raney-Ni in ethanol gives ethyl 3-(2-furyl)propionate (II), which oxidative methoxylation with Br2 in methanol affords ethyl 3-(2,5-dimethoxy-2,5-dihydro-2-furyl)propionate (III). The partial reduction of (III) with diisobutylaluminum hydride in toluene yields the substituted propionaldehyde (IV), which by a Wittig condensation with 4-carboxybutyl triphenylphosphonium bromide by means of NaH in DMSO gives 8-(2,5-dimethoxy-2,5-dihydro-2-furyl)-5-octenoic acid (VI). The hydrolytic ring opening of (VI), followed by an aldol cyclization in refluxing dioxane - water by means of sodium acetate - NaH2PO4 - hydroquinone affords 7-(2-oxo-5-hydroxycyclopent-3-en-1-yl)-5-heptenoic acid (VII), which is isomerized by treatment with H2SO4 yielding 7-(5-oxo-3-hydroxycyclopenten-1-yl)-5-heptenoic acid (VIII). Methylation and esterification of (VIII) with H2SO4/refluxing methanol gives the methoxy methyl ester (IX), which by reaction with 2-mercaptoethanol (A) and sodium methoxide in methanol is converted into methyl 7-[5-oxo-3-(2-hydroxyethylthio)cyclopenten-1-yl]-5-heptenoate (X). The methylation of acid (VI) with NaH and methyl iodide gives the corresponding methyl ester (XIV), which is submitted to a hydrolytic ring opening and aldol cyclization as before to afford methyl 7-(2-oxo-5-hydroxycyclopent-3-en-1-yl)-5-heptenoate (XV). The silylation of (XV) with trimethylchlorosilane and hexamethyldisilazane as usual yields the corresponding trimethylsilyloxy derivative (XVI), which is treated with 2-mercaptoethanol (A) and sodium methoxide to give the isomerized compound (X).

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us